IMMUSE™ Interactive Masterclass Explores Immune System Balance To Build Lifelong Resilience
Join experts on Wednesday, October 19th at 2:00 pm EDT for a lively conversation on the unique approach of balancing the immune system by using personal immunotypes.
NEW YORK, Oct. 11, 2022 /PRNewswire-PRWeb/ -- Kyowa Hakko USA, leading international health ingredient manufacturer and world leader in the development, manufacturing, and marketing of pharmaceuticals, nutraceuticals and food products, is excited to announce an interactive masterclass on Wednesday, October 19th at 2:00 pm EDT to discuss, and educate, on the innovative approach of balancing the immune system instead of boosting it to optimize health and build lifelong resilience.
World-class expert Dr. Colin Hill, in his role of board member and former president of ISAPP (International Scientific Association for Probiotics and Prebiotics), will share his unique insights about postbiotics and the opportunities they hold for human health. Dr. Heather Moday, MD, author of "The Immunotype Breakthrough," will guide the discussion on balancing the immune system by using personal immunotypes.
The "Know Your Personal Immunotype" Masterclass features IMMUSE™, a postbiotic that delivers an innovative breakthrough approach for more comprehensive immune support*. It is also aligned with the Kyowa Hakko's efforts to support the education of complex scientific topics for its customers and the public in general.
After diving in on this insightful discussion, hosted by wellness coach Jamie Hess, a lively Q&A session follows with Dr. Moday and Danielle Citrolo, PharmD. Vice President, Scientific and Regulatory Affairs at Kyowa Hakko.
To register online for the "Know Your Personal Immunotype" masterclass, visit: https://bit.ly/DrMVW2022
For media inquiries, please get in touch with Giselle Chollett at [email protected] or 917.386.7116
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
About IMMUSE™:
IMMUSE™ is a postbiotic that delivers a new, breakthrough approach to broad range immune support*. As a clinically researched immune activator* supported by over 29 published studies, including 14 human trials, IMMUSE™ proactively supports the immune system through a novel method of action that activates pDC (plasmacytoid dendritic cells) *. The pDC, a rare type of immune cell, functions as the key leader of the immune system and has been shown to activate pivotal cells such as NK, Killer-T, Helper-T, and B cells, for a more comprehensive approach to immune support*. Its unique mechanism of action, discovered by Kyowa Hakko's parent company Kirin Holdings Co., Ltd., is opening doors for discovering postbiotics concerning immune health.
About Kyowa Hakko USA:
Kyowa Hakko USA is the North & South American office of Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development, manufacturing, and marketing pharmaceuticals, nutraceuticals, and food & beverage products. Kyowa is the maker of branded ingredients, including IMMUSE™ LC-Plasma, Eyemuse™ Lacticaseibacillus paracasei KW3110, Cognizin® Citicoline, Pantesin® Pantethine, Setria® Glutathione, as well as L-Alanyl-L-Glutamine. For more information, visit http://www.kyowa-usa.com.
About Dr. Hill
Dr. Hill has a Ph.D in molecular microbiology and is Professor of Microbial Food Safety in the School of Microbiology at University College Cork, Ireland. He has been an SFI Principal Investigator since 2002. He is also a Principal Investigator in APC Microbiome Ireland. His main interests are in mining the microbiome for novel therapies, including probiotics, postbiotics, bacteriocins and bacteriophage. He has published more than 650 peer-reviewed papers and holds more than 25 patents in this area (ISI H factor of 93, Google H factor of 125). In 2005 Prof. Hill was awarded a D.Sc. by the National University of Ireland in recognition of his contributions to research. In 2009 he was elected to the Royal Irish Academy, the highest honor for an Irish academic. In 2010 he was elected to the American Academy of Microbiology and together with his colleagues Prof. Gerald Fitzgerald, Prof. Paul Ross and Dr Catherine Stanton he was awarded the Metchnikoff Prize in Microbiology. He served as President of ISAPP (International Scientific Association for Prebiotics and Probiotics) from 2012 to 2015.
About Dr. Heather Moday:
Dr. Moday is the owner of the Moday Center for Functional Medicine and Integrative Medicine, which offers comprehensive medical and nutritional programs for adults that focus on preventing and treating chronic diseases to achieve optimal wellness. She has a special interest in immune system dysfunction, including autoimmunity, allergy, the stress-immune connection, Chronic GI dysfunction, cognitive decline, and mood disorders. Dr. Moday received her MD from Tulane Medical School in New Orleans and completed a residency in Internal Medicine and a fellowship in Allergy and Immunology at Montefiore/ Albert Einstein Medical center in New York City. After years of working as an allergist in private practice, she completed a fellowship in Integrative Medicine at the Arizona Center of Integrative Medicine. She is also a certified practitioner through the Institute for Functional Medicine.
Media Contact
Maria Stanieich, Kyowa Hakko, 5514829968, [email protected]
SOURCE Kyowa Hakko
Share this article